52-Week Performance Chart

Powered by FactSet Research Systems Inc

Recent Company News

More

No news is available

Powered by FactSet Research Systems Inc.

Corporate Actions/Books Closed

More
Jun 05, 2025
Achilles Therapeutics Plc - DELISTING NOTICE - REVISED
Mar 21, 2025
Achilles Therapeutics plc - Books Closed Announcement
Feb 26, 2025
Achilles Therapeutics plc - Books Closed for Cancellation

Capital Raising Events

More
DR Price Date DR Price (USD) US/Non-US/Total DRS US/Non-US/Total DR Capital Raised
Mar 30, 2021 18.00 9,750,000
0
9,750,000
175,500,000
0
175,500,000

Institutional Ownership

TOP INSTITUTIONAL HOLDERS POSITION
BML Capital Management LLC 3,804,921
XTX Markets LLC 38,923
Brave Asset Management, Inc. 10,000
TOP MUTUAL FUND HOLDERS POSITION
Blackstone Alternative Multi Strategy Fund 1,700

Data provided by FactSet Research Systems Inc.

DR Details

CUSIP 00449L102
DR ISIN US00449L1026
Ratio DR:ORD 1:1
Underlying ISIN GB00BLH38D78
Underlying SEDOL BLH38D7
Country United Kingdom
Effective Date Apr 06, 2021
Depositary BK (Sponsored)
Industry Pharma. & Biotech.
Books Open/Closed Closed
Achilles Therapeutics plc is a United Kingdom-based clinical-stage immuno-oncology biopharmaceutical company. The Company is engaged in developing precision T cell therapies to treat multiple types of solid tumors. Its lead product is a precision tumor-derived T cell therapy targeting clonal cancer neoantigens. Its pipeline includes Chiron: Advanced Non-Small Cell Lung Cancer, Thetis: Melanoma (Monotherapy), Thetis: Melanoma (PD-1 Combination), and other indications. It is focused on advancing cancer therapies through its work in the field of tumor evolution.

Data provided by Mergent, Inc.

Fee Type in US Dollar per ADS Deposit Agreement
Annual Depositary Service up to $0.0500
Cancellation up to $0.0500
Cash Distribution up to $0.0500
Issuance up to $0.0500
Registrar Inspection up to $0.0000
Cash Distribution(Other) up to $0.0500
Rights - Issuance up to $0.0500
Stock Dividend up to $0.0500
Transfer up to $0.0000
Cable Fee per Cancellation $17.5000

Monthly Trading Summary

More
Month Month End DR Close Price DR Trading Volume Avg Day DR Trading Volume
May.25 -1.00 n/a n/a
Apr.25 -1.00 n/a n/a
Mar.25 -1.00 23,257,475 1,661,248

Powered by FactSet Research Systems Inc.

This information and data is provided for general informational purposes only.  Certain displayed prices may not reflect direct quotes from any market or exchange, but may instead reflect an approximation of price based on a methodology that includes a calculation that includes the price of underlying securities and foreign exchange rate selected for such purpose. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to Terms of Use

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE